Latest Breaking News On - Gertner institute - Page 2 : comparemela.com

TAU Study: Heart Patients Live Longer in Green Environments | The Jewish Press - JewishPress com | David Israel | 21 Adar II 5784 – Sunday, March 31, 2024

TAU Study: Heart Patients Live Longer in Green Environments | The Jewish Press - JewishPress com | David Israel | 21 Adar II 5784 – Sunday, March 31, 2024
jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.

Israel generalBeer shevaMediterranean seaOceans generalUnited kingdomState of israelArnona zivAlexandra chudnovskyNir fulmanMaya sadehMichael brauerNirit agayRachel danknerGertner instituteHealth sciencesMinistry of environmental protection

No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s

Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn't seem to increase pancreatic cancer risk in a large population-based cohort study.

Rachel danknerHealth policy researchSheba medical centerGertner institute for epidemiologyGertner instituteMalignant pancreatic neoplasmPancreatic cancerAncer of the pancreasCancer riskAlignant neoplasiaAlignant neoplasmGlp 1 receptor agonistsGlucagon like peptide 1 receptor agonistsDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetes

GLP-1s may not raise short-term pancreatic cancer risk for adults with type 2 diabetes

GLP-1s may not raise short-term pancreatic cancer risk for adults with type 2 diabetes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Bymichael monostraRachel danknerRichard smithHealth policy research at sheba medical centerClalit healthcare servicesGertner institute for epidemiologyIsrael national cancer registryGertner instituteHealth policy researchSheba medical center in israelIsrael national cancer

Pancreatic cancer: GLP-1 drugs such as Ozempic don t increase risk

Researchers say GLP-1 drugs used to treat type 2 diabetes such as Ozempic, Wegovy, and Mounjaro do not raise a person's risk of pancreatic cancer

United statesRachel danknerMir aliHealth policy researchGertner institute for epidemiologySheba medical centerDrug administrationMedical news todayGertner instituteMemorialcare surgical weight loss centerOrange coast medical centerMedical news

Analysis links high BMI in late teens to chronic kidney disease

Analysis links high BMI in late teens to chronic kidney disease
ajc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajc.com Daily Mail and Mail on Sunday newspapers.

Gertner institute for epidemiologyHealth policy researchGilad twigGertner institute